Page 233 - Read Online

Ardavanis A, Bafaloukos D, Sgouros J, Christodoulou C, Vaslamatzis of the jaw. ASCO Post 2015;6:Issue 15.
M, Linardou H, Ntalakou E, Marioli N, Stefanou D, Syrigos K. 17. Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S,
Treatment and prevention of osteonecrosis of the jaw associated with Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C. Periodontal
medication: 2009-2014. Support Care Cancer 2015;23:S1-388. disease preceding osteonecrosis of the jaw (ONJ) in cancer patients
9. Owosho AA, Scordo M, Yom SK, Randazzo J, Chapman PB, Huryn receiving antiresorptives alone or combined with targeted therapies:
JM, Estilo CL. Osteonecrosis of the jaw a new complication related report of 5 cases and literature review. Oral Surg Oral Med Oral
to Ipilimumab. Oral Oncol 2015;51:e100-1. Pathol Oral Radiol 2015;120:699-706.
10. Infante-Cossio P, Lopez-Martin JC, Gonzalez-Cardero E, Martinez- 18. Katsarelis H, Shah NP, Dhariwal DK, Pazianas M. Infection
de-Fuentes R, Casas-Fernandez-Tejerina A. Osteonecrosis of the and medication-related osteonecrosis of the jaw. J Dent Res
maxilla associated with cancer chemotherapy in patients wearing 2015;94:534-9.
dentures. J Oral Maxillofac Surg 2012;70:1587-92. 19. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz
11. Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F. Occurrence M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul
and risk indicators of medication-related osteonecrosis of the jaw C, Mufti G, Bennett J. International scoring system for evaluating
after dental extraction: a systematic review and meta-analysis. J Clin prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88.
Periodontol 2015;42:922-32. 20. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein
12. DeSesa CR, Appugounder S, Haberland C, Johnson MP. H, Thiele J, Vardiman JW. WHO Classification of Tumours of
Osteonecrosis of the jaw in association with chemotherapy in the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC;
setting of cutaneous T-cell lymphoma. J Oral Maxillofac Surg 2008;87-107.
2016;74:292-301.
13. Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayanni A, 21. http://chemocare.com/chemotherapy/drug-info/Vidaza.aspx.
Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA. Osteonecrosis Downloaded: January 2, 2016.
of the jaw in oncology patients treated with bisphosphonates: 22. Ripamonti C, Cislaghi E, Mariani L, Maniezzo M. Efficacy and
prospective experience of a dental oncology center. Oral Surg Oral safety of medical ozone (O ) delivered in oil suspension applications
3
Med Oral Pathol Oral Radiol Endod 2011;112:195-202. for the treatment of osteonecrosis of the jaw in patients with bone
14. Vardas E, Coward T, Papadopoulou E, Nicolatou-Galitis O. Dental metastases treated with bisphopshonates: Preliminary results of a
extractions as the major local risk factor of bisphosphonates phase I-II study. Oral Oncol 2011;47:185-90.
related jaw osteonecrosis in cancer patients receiving intravenous 23. Vesconi P, Giovannacci I, Merigo E, Meleti M, Manfredi M,
bisphopshonates therapy. A systematic review. Mediterr Oncol J Formaini C, Namour S. Tooth extractions in high-risk patients under
MOJ 2014;1:26-33. bisphosphonate therapy and previously affected with osteonecrosis
15. Yazdi PM, Schiodt M. Dentoalveolar trauma and minor trauma as of the jaws: surgical protocol supported by low-level Laser therapy. J
precipitating fcators for medication-related osteonecrosis of the jaw Craniofac Surg 2015;26:696-9.
(ONJ): a retrospective study of 149 consecutive patients from the 24. Basso FG, Turrioni APS, Soares DG, Hebling J, de Souza Costa
Copenhagen ONJ Cohort. Oral Surg Oral Med Oral Pathol Oral CA. Low-level laser therapy for osteonecrosis lesions: affects on
Radiol 2015;119:416-22. osteoblasts treated with zolendronic acid. Support Care Cancer
16. Migliorati CA. Dispelling the myths asscociated with osteonecrosis 2014;22:2741-8.

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦ 223